The authors concluded that the mild stimulation of GLP-1 and GIP was associated with a slower exogenous glucose rate increase, improved β-cell function (as these were type 2 diabetes patients), and reduced insulin clearance after OGTT. The gene discussed is INS; the disease is type 2 diabetes mellitus.